NCT02215018View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

August 31, 2007

Conditions
Healthy
Interventions
DRUG

BI 44370 TA solution

DRUG

BI 44370 TA tablet

DRUG

Placebo solution

DRUG

Placebo tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY